ED
SCVX

Exane Derivatives’s SCVX Corp. SCVX Stock Holding History

Exane Derivatives’s Portfolio SCVX Stock Details SCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,000
Closed -$495K – 1089
2021
Q2 		$495K Hold
50,000
– – 0.11% 184
2021
Q1 		$493K Buy
+50,000
New +$524K 0.14% 147

Other funds holding SCVX

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Exane Derivatives's SCVX Position: Q3 2021 in Review

Exane Derivatives sold out of SCVX Corp. (SCVX) in Q3 2021, closing a stake of 50,000 shares — an estimated $495K sold.

Exane Derivatives first reported a position in SCVX in Q1 2021 and held it in 2 quarters. The position peaked at $495K in Q2 2021. 68 funds tracked by Wall St. Rank hold SCVX as of Q3 2021.

  • Exane Derivatives reported no remaining SCVX Corp. position as of Q3 2021 after selling out during the quarter.
  • Exane Derivatives sold 50,000 SCVX Corp. shares in Q3 2021, an estimated $495K.
  • Exane Derivatives first reported a position in SCVX Corp. in Q1 2021 and held it in 2 quarters.
  • Exane Derivatives's SCVX Corp. position peaked at $495K in Q2 2021.
  • 68 funds tracked by Wall St. Rank held SCVX Corp. as of Q3 2021.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.